Super Low-Cost Smartphone Attachment Brings Blood Pressure Monitoring to Your Fingertips

Engineers at the University of California San Diego have developed a simple, low-cost clip that uses a smartphone's camera and flash to monitor blood pressure at the user's fingertip. The clip works with a custom smartphone app and currently costs about 80 cents to make. The researchers estimate that the cost could be as low as 10 cents apiece when manufactured at scale.

Read more ...

Transforming the Pharma Industry with Digital Health Apps (DiGA)

19 June 2023, Online.
DataArt, a global software engineering firm, is thrilled to announce its upcoming online panel discussion titled "DiGA for Pharma as Business Growth Opportunity." The event will unite professionals from the pharmaceutical, technology, and regulatory sectors to explore the transformative power of digital health apps. This discussion aims to delve into key topics, including:

Read more ...

New Model Offers a Way to Speed Up Drug Discovery

Huge libraries of drug compounds may hold potential treatments for a variety of diseases, such as cancer or heart disease. Ideally, scientists would like to experimentally test each of these compounds against all possible targets, but doing that kind of screen is prohibitively time-consuming.

In recent years, researchers have begun using computational methods to screen those libraries in hopes of speeding up drug discovery.

Read more ...

New "AI Doctor" Predicts Hospital Readmission and Other Health Outcomes

An artificial intelligence (AI) computer program can read physicians’ notes to accurately estimate patients' risk of death, length of hospital stay, and other factors important to care. Designed by a team led by researchers at NYU Grossman School of Medicine, the tool is currently in use in its affiliated hospitals to predict the chances that a patient who is discharged will be readmitted within a month.

Read more ...

Digital Tool Spots Academic Text Spawned by ChatGPT with 99% Accuracy

Heather Desaire, a chemist who uses machine learning in biomedical research at the University of Kansas, has unveiled a new tool that detects with 99% accuracy scientific text generated by ChatGPT, the artificial intelligence text generator.

The peer-reviewed journal Cell Reports Physical Science published research showing the efficacy of her AI-detection method, along with sufficient source code for others to replicate the tool.

Read more ...

Healthcare Delivery / Implementation Manager (Germany)

Doccla has recently secured its first contract in Germany, and is looking for a Delivery Manager / Implementation Specialist to ensure we delight our clients and launch our service in Germany with a bang.

Read more ...

Some Challenges in the NHS Acute Tech Market: and How to Navigate Them

NHS trusts need a lot of technology, but they face complex, structural challenges when it comes to procurement, and these tend to work against smaller companies and innovation. The Highland Marketing advisory board met recently to discuss the issues and the role of marketing.

Read more ...

AI System Predicts Consequences of Gene Modifications

Researchers at Gladstone Institutes, the Broad Institute of MIT and Harvard, and Dana-Farber Cancer Institute have turned to artificial intelligence (AI) to help them understand how large networks of interconnected human genes control the function of cells, and how disruptions in those networks cause disease.

Read more ...

Philips and Masimo Introduce New, Advanced Monitoring Capabilities to Philips High Acuity Patient Monitors

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Masimo (NASDAQ: MASI), a global medical technology company, today announced FDA clearance allowing the activation of SedLine® Brain Function Monitoring, Regional Oximetry (O3®), and CO2 measurements in Philips Patient Monitors - IntelliVue MX750 and MX850.

Read more ...

Using AI to Create Better, More Potent Medicines

While it can take years for the pharmaceutical industry to create medicines capable of treating or curing human disease, a new study suggests that using generative artificial intelligence could vastly accelerate the drug-development process.

Today, most drug discovery is carried out by human chemists who rely on their knowledge and experience to select and synthesize the right molecules needed to become the safe and efficient medicines we depend on.

Read more ...